PRIMARY STUDY

Identification of CB₂ receptors in human nigral neurons that degenerate in Parkinson's disease.

Key Findings:  These data show for the first time that CB2 receptors are located in tyrosine hydroxylase-containing neurons in the substantia nigra at levels significantly lower in PD patients compared to controls.

Type of Study:  Laboratory Study

Study Result:  Positive


Cannabinoids Studied:  Not Applicable

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable

Receptors Studied:  CB2


Study Location(s):  Italy, Spain

Year of Pub:  2015


Link to study